+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling



Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling



Cancer Research 73(13): 4075-4085



Mutations in PIK3CA, the gene encoding the p110α catalytic subunit of phosphoinositide 3-kinase (PI3K), have been shown to transform mammary epithelial cells (MEC). Studies suggest this transforming activity requires binding of mutant p110α via p85 to phosphorylated YXXM motifs in activated receptor tyrosine kinases (RTK) or adaptors. Using transgenic mice, we examined if ErbB3, a potent activator of PI3K, is required for mutant PIK3CA-mediated transformation of MECs. Conditional loss of ErbB3 in mammary epithelium resulted in a delay of PIK3CA(H1047R)-dependent mammary gland hyperplasia, but tumor latency, gene expression, and PI3K signaling were unaffected. In ErbB3-deficient tumors, mutant PI3K remained associated with several tyrosyl phosphoproteins, potentially explaining the dispensability of ErbB3 for tumorigenicity and PI3K activity. Similarly, inhibition of ErbB RTKs with lapatinib did not affect PI3K signaling in PIK3CA(H1047R)-expressing tumors. However, the p110α-specific inhibitor BYL719 in combination with lapatinib impaired mammary tumor growth and PI3K signaling more potently than BYL719 alone. Furthermore, coinhibition of p110α and ErbB3 potently suppressed proliferation and PI3K signaling in human breast cancer cells harboring PIK3CA(H1047R). These data suggest that PIK3CA(H1047R)-driven tumor growth and PI3K signaling can occur independently of ErbB RTKs. However, simultaneous blockade of p110α and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.

(PDF emailed within 0-6 h: $19.90)

Accession: 052287786

Download citation: RISBibTeXText

PMID: 23633485

DOI: 10.1158/0008-5472.CAN-12-4579


Related references

ErbB3 Loss Delays PIK3CA Mammary Hyperplasia. 2013

Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Research 65(6): 2296-2302, 2005

Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland. Oncogene 7(10): 2041-2051, 1992

Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Research 71(13): 4344-4351, 2011

Uncoupling of PI3K from ErbB3 impairs mammary gland development but does not impact on ErbB2-induced mammary tumorigenesis. Cancer Research 72(12): 3080-3090, 2012

Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. Journal of Physiology and Pharmacology 60 Suppl 1: 73-84, 2009

Studies on the mouse mammary tumor agent mta part 2 cytochemistry of amino peptidase in normal mammary gland of c 57 bl spontaneous and virus induced mammary tumors in r 111 and c 57 bl mouse strains respectively and in cell lines producing the mammary tumor virus. Acta Histochemica: 181-188, 1970

Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene. Journal of Molecular Endocrinology 36(3): 435-448, 2006

STAT3 expression in canine mammary gland tumours and mammary gland hyperplasia. European Journal of Veterinary Pathology 7(3): 117-122, 2001

Mouse models for the conditional expression of the suppressor of cytokine signaling proteins in the mammary gland. Biology of the Cell (Paris) 93(3-4): 226, October, 2001

Conditional control of gene expression in the mammary gland. Journal of Mammary Gland Biology and Neoplasia 2(4): 373-383, 2000

Thymectomy of c3h ou mice suppresses mouse mammary tumor virus expression and delays development of mammary carcinoma. FASEB Journal 4(3): A499, 1990

Generation of a floxed conditional mutant mouse for the HGF receptor gene c-met Impact of selective inactivation in liver and mammary gland. Hepatology 34(4 Pt 2): 263A, October, 2001